Showing results (2521-2530 of 8,031) with videos related to
Sort By:
Pageof 804
Current Medicinal Chemistry|October 8, 2003
Natural product inspired design of enediyne prodrugs via rearrangement of an allylic double bondWei-Min DaiCurrent Medicinal Chemistry|October 8, 2003
Virtual screening on natural products for discovering active compounds and target informationJianhua Shen, Xiaoying Xu, Feng Cheng, et al.Current Medicinal Chemistry|October 8, 2003
Mechanism of drug and toxic actions of gossypol: focus on reactive oxygen species and electron transferPeter KovacicCurrent Medicinal Chemistry|October 8, 2003
Ribozyme-based gene-inactivation systems require a fine comprehension of their substrate specificities; the case of delta ribozymeLucien Junior Bergeron, Jonathan Ouellet, Jean-Pierre PerreaultCurrent Medicinal Chemistry|October 8, 2003
Muscarinic and nicotinic cholinergic agonists: structural analogies and discrepanciesZsolt Bikádi, Miklós SimonyiCurrent Medicinal Chemistry|October 8, 2003
Microwave-assisted polymer-supported combinatorial synthesisK M K Swamy, Wen-Ben Yeh, Mei-Jung Lin, et al.Current Medicinal Chemistry|June 13, 2019
Repositioning of HIV Aspartyl Peptidase Inhibitors for Combating the Neglected Human Pathogen Trypanosoma cruziLeandro S Sangenito, Rubem F S Menna-Barreto, Cláudia M d'Avila-Levy, et al.Current Medicinal Chemistry|July 2, 2019
Redox Regulation in the Base Excision Repair Pathway: Old and New Players as Cancer Therapeutic TargetsAleksandra Rajapakse, Amila Suraweera, Didier Boucher, et al.Current Medicinal Chemistry|June 25, 2019
Formulating SLN and NLC as Innovative Drug Delivery Systems for Non-Invasive Routes of Drug AdministrationBruno Fonseca-Santos, Patrícia Bento Silva, Roberta Balansin Rigon, et al.Current Medicinal Chemistry|June 25, 2019
Secretory Clusterin as a Novel Molecular-targeted Therapy for Inhibiting Hepatocellular Carcinoma GrowthMin Yao, Wenli Sai, Wenjie Zheng, et al.Pageof 804